ClinicalTrials.Veeva

Menu

Influence of n-Acetylcysteine Maintenance on Alcohol Effects

W

William Stoops

Status and phase

Completed
Early Phase 1

Conditions

Alcohol Use Disorder

Treatments

Drug: Alcohol
Drug: Placebos
Drug: N-acetyl cysteine

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03216954
BED IN 34
R21AA026129 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study will evaluate the behavioral effects of alcohol during placebo and n-acetylcysteine maintenance using sophisticated human laboratory methods.

Enrollment

14 patients

Sex

All

Ages

21 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • able to speak/read English
  • not seeking treatment at the time of the study
  • one binge drinking episode (5+/4+ standard alcoholic drinks per drinking session for men and women, respectively) in the past 30 days
  • recent alcohol use verified by ethyl glucuronide positive urine, as well as fulfillment of DSM-5 diagnostic criteria for alcohol use disorder
  • ECG within normal limits
  • otherwise healthy
  • body mass index of 19-35
  • females using an effective form of birth control and not pregnant or breast feeding
  • judged by the medical staff to be psychiatrically and physically healthy
  • able to abstain from alcohol for 12 hours prior to session
  • no contraindications/allergies to n-acetylcysteine

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

14 participants in 3 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Subjects will receive oral placebo capsules two times daily.
Treatment:
Drug: Placebos
Drug: Alcohol
Low Dose n-Acetylcysteine
Experimental group
Description:
Subjects will receive 0.6 g oral n-acetylcysteine two times daily.
Treatment:
Drug: Alcohol
Drug: N-acetyl cysteine
High Dose n-Acetylcysteine
Experimental group
Description:
Subjects will receive 1.2 g oral n-acetylcysteine two times daily.
Treatment:
Drug: Alcohol
Drug: N-acetyl cysteine

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems